Topoisomerase III (Top3), a critical enzyme in the family of DNA topoisomerases, plays a pivotal role in the resolution of DNA topology challenges during various cellular processes, including DNA replication, transcription, and recombination. As an essential component in the maintenance of genomic stability, Top3 uniquely catalyzes the passage of one segment of DNA through another via transient breakage and rejoining of phosphodiester bonds, effectively managing DNA supercoiling and untangling. This function is indispensable for impeding the accumulation of detrimental DNA supercoils and knots that can arise during the unwinding and rewinding of the double helix. The activity of Top3 is intricately regulated within the cell, ensuring that its topoisomerase action is precisely modulated in accordance with cellular needs, thus maintaining DNA integrity and facilitating normal cellular proliferation and division.
The activation of Top3 involves a complex interplay of molecular interactions and regulatory mechanisms that ensure its enzymatic activities are closely aligned with the cellular context and the specific phase of the cell cycle. Activation mechanisms can include post-translational modifications, interaction with regulatory proteins, and the availability of cofactors that are essential for enzymatic function. For example, Top3's interaction with the RecQ family of helicases exemplifies a critical regulatory mechanism where the helicase activity is coupled with Top3's topoisomerase action to efficiently resolve DNA recombination intermediates, a process vital for maintaining genomic stability. Additionally, the binding of specific proteins can modulate Top3's activity, enhancing its ability to disentangle complex DNA structures. Cellular signaling pathways also contribute to the regulation of Top3, where signaling cascades can lead to the phosphorylation or other modifications of Top3 or its cofactors, thereby influencing its enzymatic activity. These regulatory mechanisms ensure that Top3's activity is finely tuned to the cell's requirements, enabling it to adeptly manage the topological challenges inherent to DNA metabolic processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin is a chemotherapeutic agent that has been shown to induce the expression of DNA topoisomerase III alpha | ||||||
Amsacrine hydrochloride | 54301-15-4 | sc-214540 | 10 mg | $232.00 | ||
Amsacrine is a topoisomerase II inhibitor that has been shown to induce the expression of DNA topoisomerase III alpha | ||||||
Idarubicin | 58957-92-9 | sc-507346 | 10 mg | $180.00 | ||
Idarubicin is an anthracycline antibiotic that can induce the expression of DNA topoisomerase III alpha | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic acid is a polyphenol compound found in various fruits and nuts. It has been reported to induce the expression of DNA topoisomerase III alpha | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
Podophyllotoxin is a naturally occurring lignan that inhibits topoisomerase II. Its interaction with topoisomerase II may trigger compensatory upregulation of DNA topoisomerase III alpha | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin is a platinum-based chemotherapeutic agent that can induce the expression of DNA topoisomerase III alpha | ||||||